Waters Corp (WAT)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
- Ticker
- WAT
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Market cap
- $44.20B
- 52-week range
- $282.77 - $483.33
Valuation
- Share price
- $466.10 (close of Nov 18, 2026)
- P/E (TTM)
- 191.40x
- Price to book
- 2.89x
- Price to free cash flow
- 151.99x
- Enterprise value
- $49.11B
- Book value per share
- $155.60
Price performance
| Period | Change |
|---|---|
| 1 day | +3.63% |
| 5 days | -1.02% |
| 1 month | +6.67% |
| 3 months | +16.16% |
| 6 months | +40.31% |
| Year to date | +22.71% |
| 1 year | +23.76% |
| 3 years | +77.98% |
| 5 years | +36.15% |
| 10 years | +244.80% |
| All time | +12,226.61% |
Short interest
- As of
- Oct 30, 2026
- Short % of float
- 3.39%
- Shares short
- 3.33M
- Days to cover
- 3.63
- Change since prior report
- +4.33%
- Source
- FINRA consolidated short interest
Members of Congress who disclosed WAT trades
Gilbert Ray Cisneros · Julia Letlow · Kevin Hern · Lisa McClain · Robert Bresnahan · Thomas Kean · Debbie Dingell · Tommy Tuberville
Super investors holding WAT
Terry Smith (Fundsmith LLP) · First Eagle Investment (First Eagle Investment Management, LLC) · Andreas Halvorsen (Viking Global Investors) · First Pacific Advisors (First Pacific Advisors, LP) · AKO Capital (AKO Capital LLP) · Ken Griffin (Citadel) · Bill Nygren (Harris Associates LP) · Robert Olstein (Olstein Capital Management) · Ray Dalio (Bridgewater Associates) · Mairs & Power (Mairs & Power Inc)
Profitability and growth
- Return on equity
- 25.09%
- Return on invested capital
- 17.04%
- Return on assets
- 12.66%
- Return on capital employed
- 20.92%
- Gross margin
- 59.28%
- Net margin
- 20.30%
- EBITDA margin
- 31.87%
- Revenue growth
- 6.99%
- Net income growth
- 0.75%
- Free cash flow growth
- -12.88%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 0.66%
- Current ratio
- 1.89x
- Net debt to EBITDA
- 4.26x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Revenue
- $3.17B
- Cost of revenue
- $1.29B
- Gross profit
- $1.88B
- EBITDA
- $1.01B
- Net income
- $642.63M
- Earnings per share
- $10.80
- Research and development
- $195.71M
- Interest expense
- $69.55M
- Shares outstanding
- 59.51M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|---|---|---|---|
| 2025-12-31 | $3.17B | $1.88B | $642.63M | $10.80 |
| 2024-12-31 | $2.96B | $1.76B | $637.83M | $10.75 |
| 2023-12-31 | $2.96B | $1.76B | $642.23M | $10.87 |
| 2022-12-31 | $2.97B | $1.72B | $707.75M | $11.80 |
| 2021-12-31 | $2.79B | $1.63B | $692.84M | $11.25 |
| 2020-12-31 | $2.37B | $1.36B | $521.57M | $8.40 |
| 2019-12-31 | $2.41B | $1.40B | $592.20M | $8.76 |
| 2018-12-31 | $2.42B | $1.43B | $593.79M | $7.71 |
| 2017-12-31 | $2.31B | $1.36B | $20.31M | $0.25 |
| 2016-12-31 | $2.17B | $1.28B | $521.50M | $6.46 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 59.28% | 20.30% | 25.09% | 17.04% |
| 2024-12-31 | 59.43% | 21.56% | 34.88% | 20.09% |
| 2023-12-31 | 59.57% | 21.72% | 55.83% | 20.14% |
| 2022-12-31 | 58.00% | 23.81% | 140.29% | 34.29% |
| 2021-12-31 | 58.49% | 24.87% | 188.50% | 35.98% |
| 2020-12-31 | 57.44% | 22.05% | 224.68% | 33.01% |
| 2019-12-31 | 58.00% | 24.61% | - | 39.93% |
| 2018-12-31 | 58.98% | 24.54% | 37.89% | 23.14% |
| 2017-12-31 | 58.99% | 0.88% | 0.91% | 7.82% |
| 2016-12-31 | 58.87% | 24.06% | 22.65% | 13.23% |
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $588.00M | $947.45M |
| 2024-12-31 | $325.00M | $1.63B |
| 2023-12-31 | $396.00M | $2.31B |
| 2022-12-31 | $481.00M | $1.52B |
| 2021-12-31 | $481.00M | $1.51B |
| 2020-12-31 | $443.00M | $1.21B |
| 2019-12-31 | $337.00M | $1.58B |
| 2018-12-31 | $1.74B | $1.15B |
| 2017-12-31 | $3.39B | $1.90B |
| 2016-12-31 | $2.81B | $1.70B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | $539.81M | $54.13M |
| 2024-12-31 | $619.64M | $44.71M |
| 2023-12-31 | $442.18M | $36.87M |
| 2022-12-31 | $435.74M | $42.56M |
| 2021-12-31 | $586.01M | $29.92M |
| 2020-12-31 | $618.12M | $36.87M |
| 2019-12-31 | $479.26M | $38.58M |
| 2018-12-31 | $508.37M | $37.54M |
| 2017-12-31 | $612.17M | $39.44M |
| 2016-12-31 | $547.95M | $41.00M |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-11-03 | Sep 2026 | $3.99 |
| 2026-08-04 | Jun 2026 | $3.01 |
| 2026-05-05 | Mar 2026 | $2.31 |
| 2026-02-09 | Dec 2025 | $4.50 |
| 2025-11-04 | Sep 2025 | $3.21 |
| 2025-08-04 | Jun 2025 | $2.93 |
| 2025-05-06 | Mar 2025 | $2.22 |
| 2025-02-12 | Dec 2024 | $4.02 |
Filings and sources
- Company website
- waters.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Illumina, Inc. (ILMN) · IDEXX Laboratories Inc (IDXX) · Mettler-Toledo International Inc (MTD) · IQVIA Holdings Inc. (IQV) · Quest Diagnostics Inc (DGX) · Agilent Technologies, Inc. (A) · Labcorp Holdings Inc. (LH) · Natera, Inc. (NTRA)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades